New Treatment Options for Refractory/Resistant CMV Infection

New Treatment Options for Refractory/Resistant CMV Infection

Despite advances in monitoring and treatment, cytomegalovirus (CMV) infections remain one of the most common complications after solid organ transplantation (SOT). CMV infection may fail to respond to standard first- and second-line antiviral therapies with or without the presence of antiviral resis...

Full description

Bibliographic Details
Main Authors: Carla Simone Walti, Nina Khanna, Robin K. Avery, Ilkka Helanterä
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-10-01
Series:Transplant International
Subjects:
cytomegalovirus
antiviral resistance
antiviral therapy
letermovir
maribavir
virus-specific adoptive T cell therapy
Online Access:https://www.frontierspartnerships.org/articles/10.3389/ti.2023.11785/full

Internet

https://www.frontierspartnerships.org/articles/10.3389/ti.2023.11785/full

Similar Items